Press release - Oslo, Norway, September 15, 2022: Photocure ASA , The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has communicated today on the inclusion of Hexvix®. | September 15, 2022
OSLO, Norway, Sept. 1, 2022 /PRNewswire/ Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced the appointment of Dr. Anders Neijber to the position of Chief Medical Officer
Photocure ASA: Results for the second quarter of 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ On August 9, 2022, Asieris Pharmaceuticals, a global biopharmaceutical company specializing in the discovery and development of innovative.
/PRNewswire/ Photocure ASA (Photocure, PHO: OSE) will announce the second quarter and first half year 2022 financial results on Wednesday 10 August 2022 at.